Archive · 28 Dec 2025
Blood Test Predicts HCM Complications
Scientists have found a way to use a simple blood test to help doctors understand which people with a common heart condition called hypertrophic cardiomyopathy (HCM) are at higher risk of serious problems.
HCM makes the heart muscle too thick, which can cause issues like heart failure or sudden cardiac arrest.
The test looks for a special protein in the blood that shows how hard the heart is working.
If the protein levels are high, it means the heart is under more stress and the person might need closer monitoring or treatment.
This could help doctors give the right care to the right people and make life easier for patients who worry about their future with HCM.
A blood test measures NT-Pro-BNP levels to predict HCM complications.
High NT-Pro-BNP levels indicate higher risk of heart failure and atrial fibrillation.
The test could help doctors identify high-risk patients earlier for better treatment.
Patients with lower risk could avoid unnecessary interventions.
The study involved 700 HCM patients and was led by researchers from Harvard and Oxford.
- Who
- Patients with hypertrophic cardiomyopathy (HCM) and researchers from Harvard and Oxford
- What
- Development of a blood test to predict HCM complications
- When
- Ongoing research with recent study findings
- Where
- Global, with study conducted at leading institutions
- Why
- To identify high-risk HCM patients for better treatment and to reduce unnecessary interventions
- Disease
- Hypertrophic Cardiomyopathy (HCM)
- Global Prevalence
- Millions affected
- Test Protein
- N-terminal Pro-B-type natriuretic peptide (NT-Pro-BNP)
- Study Participants
- 700 HCM patients
- Key Finding
- High NT-Pro-BNP levels indicate higher risk
- Potential Impact
- Earlier identification of high-risk patients
- Study Leaders
- Harvard and Oxford research teams
- Funding
- British Heart Foundation